Filippinene - engelsk - FDA (Food And Drug Administration)

atc healthcare international corp; distributor: atc healtchare international corp - multivitamins , minerals - capsule

Filippinene - engelsk - FDA (Food And Drug Administration)

atc health care international corp. - multivitamins , minerals - capsule - vitamin a 1,600 iu, vitamin d3 200 iu, vitamin e 10 iu, vitamin b1 1.50 mg, vitamin b2 2.16 mg, vitamin b6 2 mg, vitamin b12 2 mcg, nicotinamide 20 mg, vitamin c 100 mg, elemental iron 16 mg, elemental calcium 135.21 mg and elemental zinc 10 mg

Latvia - latvisk - Pārtikas un veterinārais dienests, Zemkopības ministrija

multipower gmbh, haleko - kapsulas

Filippinene - engelsk - FDA (Food And Drug Administration)

drugmaker's labs inc - multivitamins , minerals - tablet

Indonesia - indonesisk - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

multi produk indonesia, pt kota depok, jawa barat - padat sabun

Tanzania - engelsk - Tanzania Medicinces & Medical Devices Authority

rapid labs ltd, united kingdom - multi parameter drugs of abuse rapid test -

Tanzania - engelsk - Tanzania Medicinces & Medical Devices Authority

bimeda amea limited, - multivitamin - solution for injection - vitamin a-2000iu, vitamin d3 2000iu, vitamin e 4mg/ml, thiamine 10mg/ml, vitamin b6 5mg/ml, riboflavin phosphate sodium 1mg /ml, vitamin. b12 10mcg/ml, nicotinamide 10mg/ml, d-panthenol 1mg/ml, d-biotin 10mg/ml, calcium glycerophosphate 10mg/ml

USA - engelsk - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) ( magnesium cation - unii:t6v3lhy838, chloride ion - un - multiple electrolytes injection, type 1, usp, ph 7.4 is indicated as a source of water and electrolytes or as an alkalinizing agent. multiple electrolytes injection, type 1, usp, ph 7.4 is contraindicated in patients with a known hypersensitivity to the product. see warnings . for information on risk of air embolism – see dosage and administration. check solution container composition, lot number, and expiry date. parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. do not use solution containers in series connections. do not remove solution container from its overwrap until immediately before use. the intact port caps provide visual tamper evidence. do not use if a port cap is prematurely removed. maintain strict aseptic technique during handling. to open - always inspect the solution container before and after removal from the overwrap. - place the solution container on a clean, flat surface. using the

USA - engelsk - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - multiple electrolytes injection, type 1, usp, ph 5.5 is indicated as a source of water and electrolytes or as an alkalinizing agent. multiple electrolytes injection, type 1, usp, ph 5.5 is contraindicated in patients with a known hypersensitivity to the product. see warnings . for information on risk of air embolism – see dosage and administration. check solution container composition, lot number, and expiry date. parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. do not use solution containers in series connections. do not remove solution container from its overwrap until immediately before use. the intact port caps provide visual tamper evidence. do not use if a port cap is prematurely removed. maintain strict aseptic technique during handling. to open - always inspect the solution container before and after removal from the overwrap. - place the solution container on a clean, flat surface. using the

Filippinene - engelsk - FDA (Food And Drug Administration)

multivitamins - tablet